The purpose of this study is to develop a risk score to predict the risks of in-hospital major adverse cardiac events in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention.
The CSPR trial is an observational clinical trial to derive and validate a readily useable risk score to identify patients at high risk of in-hospital major adverse cardiac events in 5594 patients presenting with a ST-segment elevation myocardial infarction and treated by primary percutaneous coronary intervention.
Study Type
OBSERVATIONAL
Enrollment
5,594
no intervention
Renmin Hospital of Wuhan university
Wuhan, Hubei, China
in-hospital acute de novo heart failure
Killip class ≥II
Time frame: in-hospital outcome, until discharge
cardiogenic shock
according to the universal definition
Time frame: in-hospital outcome, until discharge
death
according to the universal definition
Time frame: in-hospital outcome, until discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.